• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

66.12 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 66.12
Bid (Size) 65.11 (100)
Ask (Size) 66.71 (100)
Prev. Close 66.12
Today's Range 66.12 - 66.12
52wk Range 49.26 - 70.98
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMarin (NASDAQ:BMRN) Stands Out as an Undervalued Stock with Solid Fundamentals ↗
August 24, 2026
Via Chartmill
News headline image
Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN)
August 19, 2026
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
+11.2%
+11.2%
1 Month
+9.7%
+9.7%
3 Month
+25.0%
+25.0%
6 Month
+5.6%
+5.6%
1 Year
+13.0%
+13.0%

More News

Read More
News headline image
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
August 19, 2026
Via StockStory
News headline image
3 Cash-Producing Stocks We Find Risky
August 13, 2026
Via StockStory
News headline image
BioMarin Targets Faster Deleveraging as Amicus Deal Expands Rare-Disease Growth ↗
August 12, 2026
Via MarketBeat
BioMarin Pharmaceutical (NASDAQ:BMRN): A Value Stock with Strong Fundamentals ↗
July 27, 2026
Via Chartmill
BioMarin Pharmaceutical (NASDAQ:BMRN) Presents a High-Quality Breakout Setup with Strong Technical Ratings ↗
July 25, 2026
Via Chartmill
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Shows Strong Value Potential with a 7/10 Overall Rating ↗
July 04, 2026
Via Chartmill
News headline image
BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know
August 10, 2026
Via StockStory
News headline image
BioMarin Pharmaceutical Q2 Earnings Call Highlights ↗
August 06, 2026
Via MarketBeat
Topics Earnings
News headline image
BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Impressive Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations
August 06, 2026
Via StockStory
News headline image
BioMarin Pharmaceutical (BMRN) To Report Earnings Tomorrow: Here Is What To Expect
August 04, 2026
Via StockStory
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Decent Value Play with Strong Fundamentals ↗
June 10, 2026
Via Chartmill
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Value Opportunity with Strong Fundamentals and Accelerating Growth ↗
May 19, 2026
Via Chartmill
News headline image
1 Profitable Stock with Impressive Fundamentals and 2 We Turn Down
August 03, 2026
Via StockStory
News headline image
2 Reasons to Avoid BMRN and 1 Stock to Buy Instead
July 17, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
1 of Wall Street’s Favorite Stocks with Competitive Advantages and 2 We Avoid
July 13, 2026
Via StockStory
News headline image
2 Cash-Heavy Stocks with Exciting Potential and 1 We Ignore
June 29, 2026
Via StockStory
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
June 26, 2026
Via StockStory
News headline image
Therapeutics Stocks Q1 Teardown: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest
June 24, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
2 Profitable Stocks Worth Your Attention and 1 We Find Risky
June 11, 2026
Via StockStory
News headline image
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year ↗
May 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today
May 21, 2026
Via StockStory
News headline image
1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky
May 21, 2026
Via StockStory
News headline image
2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down
May 14, 2026
Via StockStory
Topics Credit Cards

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 66.12
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 08/25/26 04:00 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 12.12B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 12B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap